BASF, the world’s largest chemicals group by sales, will cut half of the 700 jobs at its plant biotechnology business, slashing some early development projects in yield improvement and stress tolerance and all of its rice yield and corn fungal resistance projects.
BASF’s plant biotechnology unit is developing improved plant characteristics such as drought tolerability but relies on partners, the biggest being Monsanto, to bring finished seed products to market.
Alliances with such partners are not affected by the cutbacks, a spokeswoman said.
BASF, also the world’s third largest maker of farming pesticides, spends about 150 million euros ($165 million) per year on plant biotechnology research but has not disclosed sales or earnings figures for these activities.
A spokeswoman declined to comment on any cuts to annual budgets at the unit.
($1 = 0.9076 euros) (Reporting by Ludwig Burger; Editing by Maria Sheahan)
The total contract value is approximately €430 million. The project scope of work entails complete engineering services, equipment and material supply, installation and construction activities and, as an optional part of the scope, commissioning and start up.
Once it has implemented this project, Lenzing will have biological wastewater treatment plants that meet the best available techniques (BAT) quality standard at all its production sites.
The debate over the position of hydrogen in the new energy revolution has come to the fore again thanks to Japan’s hosting of the Olympic Games. But rather than showcasing how green this miracle new fuel is, it has highlighted its many problems.